{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:54:47Z","timestamp":1773294887936,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T00:00:00Z","timestamp":1480118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Development Research"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>\n<jats:table-wrap position=\"anchor\">\n\n<jats:table frame=\"hsides\">\n<jats:col\/>\n<jats:tbody>\n<jats:tr>\n<jats:td>Preclinical Research<\/jats:td>\n<\/jats:tr>\n<\/jats:tbody>\n<\/jats:table>\n<\/jats:table-wrap><\/jats:p><jats:p>The surprising results of a small clinical trial on the effects of low dose ketamine, a 65\u2010year old anesthetic drug that is also used off\u2010label for chronic pain and recreationally as a club drug, in eight depressed subjects unleashed the most significant advance in antidepressant drug development in decades. That study and subsequent ones have demonstrated that low dose, infused ketamine is able to induce a remission of depression in patients who have failed conventional medications, within 24 h. The apparent increased efficacy and rapid onset of effect of ketamine distinguish it from all other current antidepressant treatments. However, a single infusion of subanesthetic doses of ketamine produces benefits that typically last &lt;3 weeks. The infusions are associated with a transient \u201cpsychedelic\u201d experience and increased blood pressure that requires monitoring. There is also a theoretical potential to induce ketamine addiction. These features limit ketamine's ability to be a widely used treatment for depression and thus limit is ability to have a meaningful impact on the heavy morbidity and mortality associated with this disorder, despite its \u201cbreakthrough\u201d rate of efficacy and speed of action. While growing numbers of clinicians are using ketamine to treat treatment resistant depression, many in the depression field believe that the aforementioned limiting aspects need to be separated from its remarkable therapeutic effects in order to unlock the breakthrough potential of this agent. To that end, drug development efforts have focused on various features of ketamine as targets for optimization including its modulation of the NMDA receptor, its pharmacokinetics, its chirality and its active metabolites including HNK (2R, 6R)\u2010hyroxynorketamine. Drug Dev Res 77 : 489\u2013494, 2016. \u00a9 2016 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ddr.21347","type":"journal-article","created":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T04:42:40Z","timestamp":1480135360000},"page":"489-494","source":"Crossref","is-referenced-by-count":11,"title":["<scp>B<\/scp>reaking <scp>S<\/scp>ad: <scp>U<\/scp>nleashing the <scp>B<\/scp>reakthrough <scp>P<\/scp>otential of <scp>K<\/scp>etamine's <scp>R<\/scp>apid <scp>A<\/scp>ntidepressant <scp>E<\/scp>ffects"],"prefix":"10.1002","volume":"77","author":[{"given":"David","family":"Feifel","sequence":"first","affiliation":[{"name":"Department of Psychiatry University of California, San Diego, School of Medicine Gilman Drive La Jolla 9500 California, 92037 MC0957"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,11,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00230-9"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.05.028"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1987"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.62"},{"key":"e_1_2_7_6_1","unstructured":"FriedmanRA.2013. A dry pipeline for psychiatric drugs. URL: Available at:http:\/\/www.nytimes.com\/2013\/08\/20\/health\/a-dry-pipeline-for-psychiatric-drugs.html?_r=1[accessed on 19 July 2016]."},{"key":"e_1_2_7_7_1","unstructured":"HarperM.2016. Suicide has increased 24% in fifteen years the CDC says. URL: Available at:http:\/\/www.forbes.com\/sites\/matthewherper\/2016\/04\/22\/the-cdc-says-americas-suicide-rate-is-rising-dramatically\/#479d24012874[accessed on 20 July 2016]."},{"key":"e_1_2_7_8_1","first-page":"4","article-title":"History and evolution of the monoamine hypothesis of depression","volume":"61","author":"Hirschfeld RM.","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316631267"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15040465"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3504"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(03)00112-0"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905"},{"key":"e_1_2_7_14_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.24972\/ijts.2014.33.2.40","article-title":"Ketamine and depression: A review","volume":"33","author":"Ryan WC","year":"2014","journal-title":"Int J Transpers Stud"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv124"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.136"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17998"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.8.856"}],"container-title":["Drug Development Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fddr.21347","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fddr.21347","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.21347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T16:21:24Z","timestamp":1760372484000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/ddr.21347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,26]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1002\/ddr.21347"],"URL":"https:\/\/doi.org\/10.1002\/ddr.21347","archive":["Portico"],"relation":{},"ISSN":["0272-4391","1098-2299"],"issn-type":[{"value":"0272-4391","type":"print"},{"value":"1098-2299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,26]]}}}